| BRIEF REPORT |
|
| Year : 2022 | Volume
: 17
| Issue : 4 | Page : 189-192 |
|
|
Lung cancer screening in the gulf: Rationale and recommendations
Sami M Bennji1, B Jayakrishnan1, Adil H Al-Kindi2, Issa Al-Jahdhami3, Zamzam Al-Hashami1
1 Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman
2 Division of Cardiothoracic Surgery, Sultan Qaboos University Hospital, Muscat, Oman
3 Department of Medicine, Armed Forces Hospital, Muscat, Oman
Correspondence Address:
Dr. Sami M Bennji
Sultan Qaboos Comprehensive Cancer Care and Research Center, P. O. Box: 566; PC: 123, Muscat
Oman
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/atm.atm_69_22
|
|
|
Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable to cure at the time of presentation. Therefore, the emphasis on lung cancer screening (LCS) is growing with the current evidence that has shown benefits with low-dose computed tomography scan of the chest in high-risk populations. LCS remains a debated topic in Gulf Cooperation Council (GCC) countries, possibly due to a lack of local experience. In this article, we explore the rationale and give recommendations on the best approach for LCS in GCC.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
